August 16, 2016 - Curant Health COO, Marc O'Connor, in Specialty Pharmacy Times - When Specialty Pharmacy Times editorial team proffered the topic of cost versus cure, and the responsibility of the payer (including the employer and patient), prescriber, patient or pharmacy, I hesitated. Answering the question by making one party more responsible than another reinforces […]
Curant Health is so much more than a specialty pharmacy. We treat our patients like family and are personally invested in nurturing long-term patient-care team relationships. So what makes us different? Start with the high touch, patient-centric support we offer to all of our patients. We use data to help clinicians and payers identify which […]
August 10, 2016 – Atlanta, Georgia – Curant Health, provider of personalized medication management services, has formed a partnership with Louisiana Physicians ACO (LPACO), to deliver a coordinated, structured medication management program for selected Medicare patients Initial program focus will be on patients with one or more of the following chronic conditions: diabetes, congestive heart […]
Dr. Sharon Dudley-Brown and Vickie Andros, PharmD, present study results at ACG 2016 At Curant Health, proving the value of our medication therapy management protocols and patient support services is paramount to our mission of improving lives and outcomes for patients with chronic conditions. As such, we want to express enthusiastic congratulations to Dr. Sharon […]
August 1, 2016 - Curant Health COO, Marc O'Connor, in Managed Healthcare Executive - The Centers for Medicare and Medicaid Services (CMS) implemented the Five Star Quality Rating System to help educate consumers on quality of healthcare and make healthcare quality data more transparent. Health plans are rated on multiple measures, five of which are […]
The fee-for-service design of the healthcare industry has been the standard for the last 50-75 years. The simple fact remains that many stakeholders are still heavily invested in prolonging its tenure, even as irreversible steps are taken to ensure its eventual demise. As we make the inevitable transition to value-based care, certain questions still need […]
The FDA has programs in place to focus on the development and designations for new specialty drugs. The problem is that high prices are being paid for drugs that don’t come with a graded, tested and proven high outcomes guarantee. The Institute for Clinical and Economic Review (ICER) evaluates evidence on the value of medical […]
July 9, 2016 - Curant Health COO, Marc O'Connor, featured in Managed Healthcare Executive - HHS is taking formal steps to address opioid addiction, a widely recognized national public health crisis. These steps include expanding access to buprenorphine—a drug used to treat opioid addiction—a proposal to eliminate any potential financial incentive for doctors to prescribe […]
July 5, 2016 – Atlanta, Georgia – One of the nation’s largest independent 340B specialty pharmacies, Curant Health, announces the launch of four new 340B clinic partnerships beginning July 1, 2016: South Health District - Valdosta, Georgia University of Miami AIDS Clinical Research - Miami, Florida Genesis Health Care, Inc. - Darlington, South Carolina Morehouse […]
When discussing high cost drugs proven to cure a specific illness, such as hepatitis C treatment, it’s important to keep the following in mind: All stakeholders - manufacturers, pharmacy benefit managers, pharmacies, payers and business owners - want a say in determining the cost of certain drugs because they all assume a certain level of […]
